Navigation Links
Acceliant Participates as Platinum Sponsor at the SCDM Annual Conference in Los Angeles

LOS ANGELES and HERNDON, Virginia, September 18, 2012 /PRNewswire/ --

Acceliant is expanding the boundaries of eClinical trial technologies by delivering an end-to end clinical trial solution integrating Electronic Data Capture (EDC) and Patient Reported Outcomes (e-PRO) to support various clinical development activities in the life sciences industry. At the SCDM 2012 Annual Conference, held in Los Angeles Sep. 22-25, Acceliant, a Platinum sponsor, will showcase "Integration of e-PRO through multi-modal data capture with the power of EDC."

A product demonstration is slated for September 24 at 7:15 a.m. in the Platinum Ballroom, Salons I-JW Marriott Live Hotel. Join us for hands-on experience on the technology in this session. Acceliant also invites all conference attendees to visit Booth #200 where Acceliant will showcase the integration of several new EDC and e-PRO modules.

Ven Thangaraj, CTO of Acceliant said, "Globally, Clinical Data Management Practice takes advantage of new data gathering technologies and processes to improve the speed and quality of data collection and rapidly merge it with EDC systems. Acceliant has developed a single EDC/e-PRO system that offers a superior solution by allowing study data to be readily available, eliminating integration costs. Acceliant will also showcase several of its proprietary solutions on the SCDM platform for pharmaceutical, biotech, and CROs who spend considerable time and money in the selection process."

Sri Manchala, CEO and President of Acceliant said, "The SCDM Annual Conference is an important event attended by clinical professionals and experts from the life sciences industry globally. It's like bringing the entire marketplace to one location. We strongly believe that SCDM, as a platform, brings us closer to our clients in understanding the challenges they face and developing innovative solutions that add value."

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is a preeminent offering that continues its 11-year expertise in providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to easily implement and deploy solutions in response to data, functional, and analytic needs.

Prashant Bhavaraju
CMO, Acceliant

SOURCE Acceliant
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
2. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
3. Misonix Participates In Cleveland Spine Review
4. BlackStratus participates in Joint FDA-ISPE CGMP Conference
5. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
6. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
7. Nonin Medical Named Platinum Partner by Tri-anim Health Services
8. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
9. Camfil Farr to Sponsor, Participate in Premier Pharma Manufacturing Conference
10. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
11. Sae-A Trading Sponsors Medical Mission to Haiti
Post Your Comments:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
Breaking Medicine News(10 mins):